Global COVID-19 Diagnosis Market Size, Status and Forecast 2021-2027

The COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incidence of the infection is observed to be increasing daily in the Americas, Europe, and Africa. Although several strains of coronavirus have been identified and studied earlier, the new disease has been caused due to a novel strain and in no time turned into a pandemic due to a high R-naught. The virus is expected to impact the socioeconomic and political landscape of the countries, consequently leading to adverse economic impact.

In 2021, the global COVID-19 Diagnosis market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 Diagnosis status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 Diagnosis development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global COVID-19 Diagnosis Scope and Market Size
COVID-19 Diagnosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
RT-PCR
Isothermal Nucleic Acid Amplification
Others

Segment by Application
Hospital
Laboratory

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Cepheid
Abbott
Mesa Biotech
Microsens Dx
GenMark Diagnostics
Credo